India reports over 2 lakh new Covid cases for third day in a row; PM to hold review meeting
India is currently reporting the sharpest growth rate of 7.6 per cent in new Covid cases, which is 1.3 times higher than case growth rate of 5.5% reported in June 2020.
India on Saturday reported 2,34,692 new cases in the last 24 hours. This is the third day in a row that the country is reporting over two lakh new cases.
With this, India's total active caseload tally has touched 16,79,740.
Prime Minister Narendra Modi will hold a meeting at 8 pm on Saturday to review the COVID-19 and vaccination situation in India. Top officers across various ministries will participate.
India is reporting the sharpest growth rate of 7.6 per cent in new Covid cases, which is 1.3 times more than the case growth rate of 5.5% reported in June 2020.
Ten states -- Maharashtra, Uttar Pradesh, Delhi, Chhattisgarh, Karnataka, Madhya Pradesh, Kerala, Gujarat, Tamil Nadu and Rajasthan -- together contribute 79.32 per cent of the new cases.
Maharashtra reported the highest daily new cases (63,729) in the last 24 hours, followed by Uttar Pradesh (27,360) and Delhi (19,486).
The second wave of covid-19 is sweeping through the country, with as many as 16 states reporting an upward trajectory in daily new cases.
As for recoveries, the national rate is 87.23 per cent. A total of 1,23,354 people have been cured in the last 24 hours.
Covid fatalities set a new record, with 1,341 succumbing to the virus in the last 24 hours. Once again, the top 10 states accounted for 85.83% of the new deaths, with Maharashtra suffering maximum casualties (398), followed by Delhi (141).
Union Health Minister Dr Harsh Vardhan chaired a high-level meeting with the health ministers of 11 states and Union Territories to review measures taken to prevent, contain and manage the recent surge in cases.
During the meeting, the state health ministers raised issues like increasing the supply of oxygen cylinders, ramping up the supply of Remdesivir in hospitals, adding to the ventilator stock and enhancing the supply of vaccine doses.
Some states also raised their concerns about Medical Oxygen supply lines and sought the capping of prices of essential drugs like Remdesivir, which has been sold in the black market at exorbitant prices.